Professional Documents
Culture Documents
SCPAA3 Week 3 Slide Deck
SCPAA3 Week 3 Slide Deck
Eduvos (Pty) Ltd (formerly Pearson Institute of Higher Education) is registered with the Department of Higher Education and Training as a private higher education institution under the
Higher Education Act, 101, of 1997. Registration Certificate number: 2001/HE07/008
Week 3: Lesson 5
Introduction
In this week you will learn about catalytic mechanisms: The types of catalytic mechanisms
that enzymes employ have been classified as:
1.Acid–base catalysis
2.Covalent catalysis
3.Metal ion catalysis
4.Proximity and orientation effects
5.Preferential binding of the transition state complex
What will be covered
in today’s lesson?
Contrasting the chemical basis for
acid-base catalysis, covalent catalysis
and metal ion catalysis.
Week 3
Lesson 5 Discussing how enzymes accelerate
reactions through proximity and
orientation effects and by preferential
binding of the transition state
• Source:
1. Acid–base catalysis
2. Covalent catalysis
3. Metal ion catalysis
4. Proximity and orientation effects
5. Preferential binding of the transition state complex
5
Drawing reaction mechanism (Box 11-1)
• We use curved arrow convention to show how pairs of electrons are rearranged
during a reaction.
• Focus on the more common two-electron reactions
• The movement of an electron pair is symbolized by a curved arrow starting at the
electron rich centre pointing towards the electron deficient centre
Bond Breakage:
Bond Forming:
6
Drawing reaction mechanism (Box 11-1)
Tautomers are two molecules with the same molecular formula but
different connectivity - constitutional isomers, in other words - which can
interconvert in a rapid equilibrium. Can be seen in relocation of a proton
Uncatalyzed
8
Figure 11-8 © 2017 John Wiley & Sons, Inc. All rights reserved
Activity
Figure 11-10 © 2017 John Wiley & Sons, Inc. All rights reserved 11
The RNase A mechanism
Figure 11-10 © 2017 John Wiley & Sons, Inc. All rights reserved 12
The RNase A mechanism
13
Figure 11-10 © 2017 John Wiley & Sons, Inc. All rights reserved
Covalent catalysis usually requires a nucleophile
Covalent catalysis accelerates reaction rates through the transient formation of a catalyst–
substrate covalent bond.
14
Biologically important nucleophilic & electrophilic groups
Figure 11-12 © 2017 John Wiley & Sons, Inc. All rights reserved 15
Biologically important nucleophilic groups
Lysine
Histidine
16
Figure 11-12 © 2017 John Wiley & Sons, Inc. All rights reserved
Biologically important electrophilic groups
17
Figure 11-12 © 2017 John Wiley & Sons, Inc. All rights reserved
Decarboxylation of aceto-acetate
Figure 11-11 © 2017 John Wiley & Sons, Inc. All rights reserved 18
Schiff base formation
Uncatalyzed
Elimination of
Nucleophile reaction catalyst
Catalyzed by
primary
amine
Figure 11-11 © 2017 John Wiley & Sons, Inc. All rights reserved 20
Metal ion cofactors act as catalysts
21
Role of Zn2+ in carbonic anhydrase
Figure 11-13 b) © 2017 John Wiley & Sons, Inc. All rights reserved 22
Activity
Discuss how enzymes accelerate reactions through
proximity and orientation effects and by preferential
binding of the transition state
Catalysis via proximity & orientation
Reaction 1
Reaction 2
By simply binding their substrates, enzymes facilitate their catalyzed reactions in four
ways:
1. Enzymes bring substrates into contact with their catalytic groups. Proximity effects alone can
enhance reaction rates by no more than a factor of 5.
2. Enzymes bind their substrates in the proper orientations for reaction. It is estimated that properly
orienting substrates can increase reaction rates by a factor of up to 100.
3. Charged groups may help stabilize the transition state of the reaction, a phenomenon termed
electrostatic catalysis. The expulsion of water from the active site may enhance this effect. The
charge distribution around the active sites of enzymes may also guide polar substrates toward
their binding site.
4. Enzymes freeze out the relative translational and rotational motions of their substrates and
catalytic groups. This effect can promote rate enhancements of up to 107
25
Geometry of SN2 reaction – binding with proper orientation
Figure 11-14 © 2017 John Wiley & Sons, Inc. All rights reserved 26
Catalysis via preferential transition state binding
27
© 2017 John Wiley & Sons, Inc. All rights reserved
Catalysis via preferential transition state binding
• Enzymes bind the transition state with higher affinity than the substrate
or product
• A good substrate does not need to bind tightly to the enzyme but must
bind tightly when activated to the transition state
28
© 2017 John Wiley & Sons, Inc. All rights reserved
Catalysis via preferential transition state binding
29
© 2017 John Wiley & Sons, Inc. All rights reserved
Catalysis via preferential transition state binding
Animation link
Figure 11-15 © 2017 John Wiley & Sons, Inc. All rights reserved 30
Inhibition by transition state analogs
Figure 11-16 © 2017 John Wiley & Sons, Inc. All rights reserved
34
Chair & Half-chair conformations
1
2
6
3 5
4
Figure 11-18 © 2017 John Wiley & Sons, Inc. All rights reserved 35
Identification of lysozyme cleavage site
37
© 2017 John Wiley & Sons, Inc. All rights reserved
Lysozyme reaction mechanism
38
Figure 11-21 © 2017 John Wiley & Sons, Inc. All rights reserved
Lysozyme reaction mechanism
1
1
Figure 11-21 © 2017 John Wiley & Sons, Inc. All rights reserved 39
Lysozyme reaction mechanism
1
1
40
Figure 11-21 © 2017 John Wiley & Sons, Inc. All rights reserved
Lysozyme reaction mechanism
41
Figure 11-21 © 2017 John Wiley & Sons, Inc. All rights reserved
Lysozyme reaction mechanism
42
Figure 11-21 © 2017 John Wiley & Sons, Inc. All rights reserved
Lysozyme reaction mechanism
43
Figure 11-21 © 2017 John Wiley & Sons, Inc. All rights reserved
Outcome 2 – Lysozyme: Transition state analog inhibitor
44
Figure 11-22 © 2017 John Wiley & Sons, Inc. All rights reserved
Outcome 2 – Position of D-Ring lysozyme catalysis
Covalent glycosyl-enzyme
intermediate of HEW lysozyme
PDBid 1H6M
45
Figure 11-23 © 2017 John Wiley & Sons, Inc. All rights reserved
Outcome 2 – Inhibitor used to verify covalent lysozyme
intermediate